In today's world, ADB-FUBHQUCA is a topic that has sparked a lot of interest and debate. From its origins to its evolution today, ADB-FUBHQUCA has had a significant impact on various areas of society. Its influence has extended to aspects such as economics, politics, culture and technology, generating both admiration and controversy. In this article, we will explore in depth the various aspects related to ADB-FUBHQUCA, analyzing its impact in different contexts and examining the implications it has today.
![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H26FN3O2 |
Molar mass | 395.478 g·mol−1 |
3D model (JSmol) | |
| |
|
ADB-FUBHQUCA is a synthetic cannabinoid receptor agonist that has been sold as a designer drug, first reported in 2022. It is related to the previously reported compound ADB-FUBICA but with the central indole ring system expanded to a 1,4-dihydroquinoline structure. This breaks the aromaticity of the ring system, and ADB-FUBHQUCA is relatively low in potency compared to related compounds where the aromatic core is retained.